Lipocine Inc. has initiated the BLOOM Phase 3 clinical trial to evaluate LPCN 1154, an oral brexanolone treatment for severe postpartum depression (PPD). The study plans to enroll about 120 participants, aiming to provide rapid symptom relief through a 48-hour at-home oral regimen. This trial follows a prior Phase 3 study that showed safety but did not meet primary endpoints, with new measures to improve data quality and reduce placebo effects. Lipocine expects to fund the study with existing resources and aims to support a future regulatory submission if results are positive.
Lipocine's new Phase 3 study initiation is the focus, with Pluang data showing a breadth of 91 priced US health-sector stocks, where 50 rose and 28 fell as of Sep 14, 2026 18:52 WIB. Among notable movers, Sanofi SA (SNY) rose 1.71% to USD 43.50, while Aurora Cannabis Inc (ACB) and Recursion Pharmaceuticals Inc (RXRX) fell 1.74% and 1.72% respectively, priced at USD 3.67 and USD 3.15.
WeShop Holdings Limited announced that eligible UK members can start claiming Class A ordinary shares on November 23, marking one year since its Nasdaq listing. Members earn WePoints through shopping, which can now be converted into company shares un...
Logile held its inaugural Connect EMEA event on October 14, 2026, gathering UK and EMEA retail leaders like bp, Booths, Co-op, and Morrisons to discuss integrating store planning with execution through AI-powered connected workforce solutions. The ev...
The global motorsports market is projected to grow from $11.45 billion in 2026 to $16.17 billion by 2031, with a CAGR of 7.15%. Growth is fueled by expanding digital rights, streaming platforms, and increased sponsorship opportunities, especially in ...
YYForce Inc. announced a new integrated platform that connects human expertise, AI, robotics, and IoT systems to enhance hotel operations. This platform aims to coordinate staffing, robotic tasks, and building performance, preparing the hospitality s...
YYForce Inc. announced its vision to develop an integrated platform that combines human expertise, AI, robotics, and IoT systems to support next-generation smart hotel operations. The platform aims to coordinate staffing, service delivery, robotic ta...
